Basic information Safety Supplier Related

Tipiracil

Basic information Safety Supplier Related

Tipiracil Basic information

Product Name:
Tipiracil
Synonyms:
  • Tipiracil
  • Tipiracil (hydrochloride)
  • 2,4(1H,3H)-PyriMidinedione,5-chloro-6-[(2-iMino-1-pyrrolidinyl)Methyl] hydrochloride
  • 5-Chloro-6-[(2-imino-1-pyrrolidinyl)methyl]-2,4(1H,3H)-pyrimidinedione monohydrochloride
  • Tipiracil HCl
  • 5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1H-pyrimidine-2,4-dione,hydrochloride
  • 5-Chloro-6-(2-iminopyrrolidin-1-ylmethyl)-1,2,3,4-tetrahydropyrimidine-2,4-dione hydrochloride
  • 5-Chloro-6-(2-iminopyrrolidin-1-ylmethyl)uracil hydrochloride
CAS:
183204-72-0
MF:
C9H12Cl2N4O2
MW:
279.12318
Product Categories:
  • Inhibitors
  • API
Mol File:
183204-72-0.mol
More
Less

Tipiracil Chemical Properties

Melting point:
245℃ (decomposition)
storage temp. 
2-8°C
solubility 
DMSO (Slightly, Heated), Water (Slightly)
form 
powder
color 
white to beige
Stability:
Hygroscopic
More
Less

Tipiracil Usage And Synthesis

Description

Tipiracil (TPI) is a potent and competitive inhibitor of thymidine phosphorylase (TPase) with an IC50 value of 35 nM for human placental TPase. It is selective for TPase over other pyrimidine-metabolizing enzymes (IC50s = >1 mM for UPase, OPRTase, TK, and DPDase). TPI inhibits the phosphorolysis and degradation of trifluorothymidine , a cytotoxic nucleoside, in human breast and colon carcinoma tumor samples. Oral administration of TPI (12.5-50 mg/kg) enhances the anti-tumor activity of trifluorothymidine in a mouse AZ-521 stomach cancer xenograft model. Formulations containing TPI have been used for the treatment of metastatic colorectal cancer.

Uses

Tipiracil Hydrochloride serves as a treatment for metastatic colorectal cancer (mCRC). A thymidine phosphorylase inhibitor.

Definition

ChEBI: A hydrochloride obtained by combining tipiracil with one equivalent of hydrochloric acid. Used in combination with trifluridine, a nucleoside metabolic inhibitor, for treatment of advanced/relapsed unresectable colorectal cancer.

Biochem/physiol Actions

Tipiracil is an inhibitor of thymidine phosphorylase. Tipiracil is used in combination with trifluridine as TAS-102 for the treatment of refractory metastatic colorectal cancer. Tipiracil increases the bioavailability of trifluridine by blocking the enzyme that would otherwise protect the tumors by metabolizing trifluridine.

target

thymidine phosphorylase

References

1. tsukihara h1, nakagawa f2, sakamoto k et al. efficacy of combination chemotherapy using a novel oral chemotherapeutic agent, tas-102, together with bevacizumab, cetuximab, or panitumumab on human colorectal cancer xenografts. oncol rep. 2015 may;33(5):2135-42. 2. dexter dl, wolberg wh, ansfield fj, helson l and heidelberger c: the clinical pharmacology of 5-trifluoro-methyl-2'-deoxyuridine. cancer res 32: 247-253, 1972.3. fukushima m, suzuki n, emura t et al. structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2'-deoxyribonucleosides. biochem pharmacol 59: 1227-1236, 2000.

TipiracilSupplier

Shanghai Yu Ben Biotechnology Co., Ltd. Gold
Tel
15502154572
Email
yuben012@sina.com
Shandong Jirun Biomedical Technology Co., Ltd. Gold
Tel
0539-0539-8613587 17661611089
Email
2639273505@qq.com
Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Adamas Reagent, Ltd.
Tel
400-6009262 16621234537
Email
chenyj@titansci.com
Shanghai Sphchem Co., Ltd.
Tel
21-21-56491756 13512199871
Email
sales@panhongchem.com